Cargando…

Repurposing of KLF5 activates a cell cycle signature during the progression from a precursor state to oesophageal adenocarcinoma

Oesophageal adenocarcinoma (OAC) is one of the most common causes of cancer deaths. Barrett’s oesophagus (BO) is the only known precancerous precursor to OAC, but our understanding about the molecular events leading to OAC development is limited. Here, we have integrated gene expression and chromati...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogerson, Connor, Ogden, Samuel, Britton, Edward, Ang, Yeng, Sharrocks, Andrew D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544504/
https://www.ncbi.nlm.nih.gov/pubmed/32880368
http://dx.doi.org/10.7554/eLife.57189
_version_ 1783591869100326912
author Rogerson, Connor
Ogden, Samuel
Britton, Edward
Ang, Yeng
Sharrocks, Andrew D
author_facet Rogerson, Connor
Ogden, Samuel
Britton, Edward
Ang, Yeng
Sharrocks, Andrew D
author_sort Rogerson, Connor
collection PubMed
description Oesophageal adenocarcinoma (OAC) is one of the most common causes of cancer deaths. Barrett’s oesophagus (BO) is the only known precancerous precursor to OAC, but our understanding about the molecular events leading to OAC development is limited. Here, we have integrated gene expression and chromatin accessibility profiles of human biopsies and identified a strong cell cycle gene expression signature in OAC compared to BO. Through analysing associated chromatin accessibility changes, we have implicated the transcription factor KLF5 in the transition from BO to OAC. Importantly, we show that KLF5 expression is unchanged during this transition, but instead, KLF5 is redistributed across chromatin to directly regulate cell cycle genes specifically in OAC cells. This new KLF5 target gene programme has potential prognostic significance as high levels correlate with poorer patient survival. Thus, the repurposing of KLF5 for novel regulatory activity in OAC provides new insights into the mechanisms behind disease progression.
format Online
Article
Text
id pubmed-7544504
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-75445042020-10-09 Repurposing of KLF5 activates a cell cycle signature during the progression from a precursor state to oesophageal adenocarcinoma Rogerson, Connor Ogden, Samuel Britton, Edward Ang, Yeng Sharrocks, Andrew D eLife Cancer Biology Oesophageal adenocarcinoma (OAC) is one of the most common causes of cancer deaths. Barrett’s oesophagus (BO) is the only known precancerous precursor to OAC, but our understanding about the molecular events leading to OAC development is limited. Here, we have integrated gene expression and chromatin accessibility profiles of human biopsies and identified a strong cell cycle gene expression signature in OAC compared to BO. Through analysing associated chromatin accessibility changes, we have implicated the transcription factor KLF5 in the transition from BO to OAC. Importantly, we show that KLF5 expression is unchanged during this transition, but instead, KLF5 is redistributed across chromatin to directly regulate cell cycle genes specifically in OAC cells. This new KLF5 target gene programme has potential prognostic significance as high levels correlate with poorer patient survival. Thus, the repurposing of KLF5 for novel regulatory activity in OAC provides new insights into the mechanisms behind disease progression. eLife Sciences Publications, Ltd 2020-09-03 /pmc/articles/PMC7544504/ /pubmed/32880368 http://dx.doi.org/10.7554/eLife.57189 Text en © 2020, Rogerson et al http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Cancer Biology
Rogerson, Connor
Ogden, Samuel
Britton, Edward
Ang, Yeng
Sharrocks, Andrew D
Repurposing of KLF5 activates a cell cycle signature during the progression from a precursor state to oesophageal adenocarcinoma
title Repurposing of KLF5 activates a cell cycle signature during the progression from a precursor state to oesophageal adenocarcinoma
title_full Repurposing of KLF5 activates a cell cycle signature during the progression from a precursor state to oesophageal adenocarcinoma
title_fullStr Repurposing of KLF5 activates a cell cycle signature during the progression from a precursor state to oesophageal adenocarcinoma
title_full_unstemmed Repurposing of KLF5 activates a cell cycle signature during the progression from a precursor state to oesophageal adenocarcinoma
title_short Repurposing of KLF5 activates a cell cycle signature during the progression from a precursor state to oesophageal adenocarcinoma
title_sort repurposing of klf5 activates a cell cycle signature during the progression from a precursor state to oesophageal adenocarcinoma
topic Cancer Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544504/
https://www.ncbi.nlm.nih.gov/pubmed/32880368
http://dx.doi.org/10.7554/eLife.57189
work_keys_str_mv AT rogersonconnor repurposingofklf5activatesacellcyclesignatureduringtheprogressionfromaprecursorstatetooesophagealadenocarcinoma
AT ogdensamuel repurposingofklf5activatesacellcyclesignatureduringtheprogressionfromaprecursorstatetooesophagealadenocarcinoma
AT brittonedward repurposingofklf5activatesacellcyclesignatureduringtheprogressionfromaprecursorstatetooesophagealadenocarcinoma
AT repurposingofklf5activatesacellcyclesignatureduringtheprogressionfromaprecursorstatetooesophagealadenocarcinoma
AT angyeng repurposingofklf5activatesacellcyclesignatureduringtheprogressionfromaprecursorstatetooesophagealadenocarcinoma
AT sharrocksandrewd repurposingofklf5activatesacellcyclesignatureduringtheprogressionfromaprecursorstatetooesophagealadenocarcinoma